The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes

HER2-low breast cancer (BC) is a newly defined subset of HER2-negative BC. However, it is still uncertain whether HER2-low BC can be categorized as a distinct biological/clinical subgroup with any prognostic significance. Invasive BC cases (n = 10,215) with Stage I-III were retrospectively analyzed...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical breast cancer 2024-07, Vol.24 (5), p.431-438
Hauptverfasser:	Nishimura, Reiki, Fujiki, Yoshitaka, Taira, Tetsuhiko, Miyaki, Toshiko, Kanemitsu, Shuichi, Yotsumoto, Daisuke, Teraoka, Megumi, Kawano, Junko, Gondo, Naomi, Mitsueda, Reiko, Baba, Shinichi, Ohi, Yasuyo, Rai, Yoshiaki, Sagara, Yoshiaki, Sagara, Yasuaki
Format:	Artikel
Sprache:	eng
Schlagworte:	Factors for survival Neoadjuvant chemotherapy Pathological complete response Recurrence Survival
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!